enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Lipodystrophy - Wikipedia

    en.wikipedia.org/wiki/Lipodystrophy

    (Although, in some cases, rotation of the injection sites may not be enough to prevent lipodystrophy.) [citation needed] Some of the side-effects of lipodystrophy are the rejection of the injected medication, the slowing down of the absorption of the medication, or trauma which can cause bleeding that, in turn, causes rejection of the medication.

  3. Lipodermatosclerosis - Wikipedia

    en.wikipedia.org/wiki/Lipodermatosclerosis

    The exact cause of lipodermatosclerosis is unknown. [3] [6] Venous disease, such as venous incompetence, venous hypertension, and body mass may be relevant to the underlying pathogenesis. [3] Increased blood pressure in the veins (venous hypertension) can cause diffusion of substances, including fibrin, out of capillaries.

  4. Necrobiosis lipoidica - Wikipedia

    en.wikipedia.org/wiki/Necrobiosis_lipoidica

    Necrobiosis lipoidica is a rare, chronic skin condition predominantly associated with diabetes mellitus (known as necrobiosis lipoidica diabeticorum or NLD). [1] It can also occur in individuals with rheumatoid arthritis or without any underlying conditions (). [2]

  5. Localized lipodystrophy - Wikipedia

    en.wikipedia.org/wiki/Localized_lipodystrophy

    Localized lipodystrophy is a skin condition characterized by the loss of subcutaneous fat localized to sites of insulin injection. [1]: ...

  6. Lipoatrophy - Wikipedia

    en.wikipedia.org/wiki/Lipoatrophy

    Lipoatrophy is the term describing the localized loss of fat tissue.This may occur as a result of subcutaneous injections of insulin in the treatment of diabetes, from the use of human growth hormone or from subcutaneous injections of copaxone used for the treatment of multiple sclerosis.

  7. Familial partial lipodystrophy - Wikipedia

    en.wikipedia.org/wiki/Familial_partial_lipodystrophy

    Familial partial lipodystrophy, also known as Köbberling–Dunnigan syndrome, [2] is a rare genetic metabolic condition characterized by the loss of subcutaneous fat. [ 3 ] : 495 FPL also refers to a rare metabolic condition in which there is a loss of subcutaneous fat in the arms, legs and lower torso.

  8. ‘No one should have to be fighting cancer and insurance at ...

    www.aol.com/no-one-fighting-cancer-insurance...

    Instead of being able to calmly focus on her chemotherapy treatment, Arete Tsoukalas had to spend hours on the phone arguing with her insurer while receiving infusions in the hospital.

  9. Glossary of diabetes - Wikipedia

    en.wikipedia.org/wiki/Glossary_of_diabetes

    They are harmless. See also: Lipoatrophy; injection site rotation. Insulin-induced hypertrophy Small lumps that form under the skin when a person keeps injecting a needle in the same spot. See also: Lipodystrophy; injection site rotation. Insulin pen An insulin injection device the size of a pen that includes a needle attached to a vial of insulin.